Aigen Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,515
Closed -$1.17M 876
2024
Q1
$1.17M Buy
3,515
+2,340
+199% +$715K 0.26% 110
2023
Q4
$318K Sell
1,175
-2,169
-65% -$536K 0.06% 465
2023
Q3
$823K Sell
3,344
-888
-21% -$243K 0.16% 206
2023
Q2
$1.28M Buy
+4,232
New +$1.18M 0.19% 149
2022
Q3
Sell
-14,933
Closed -$2.51M 645
2022
Q2
$2.51M Buy
+14,933
New +$3.21M 0.42% 64
2022
Q1
Sell
-12,520
Closed -$3.04M 766
2021
Q4
$3.04M Buy
+12,520
New +$3.06M 0.19% 146
2021
Q3
Sell
-8,594
Closed -$1.78M 550
2021
Q2
$1.78M Buy
8,594
+6,293
+273% +$1.28M 0.31% 87
2021
Q1
$433K Buy
+2,301
New +$406K 0.06% 320
2020
Q3
Sell
-48,097
Closed -$4.67M 962
2020
Q2
$4.67M Buy
48,097
+27,044
+128% +$2.81M 0.6% 13
2020
Q1
$1.89M Buy
21,053
+20,843
+9,925% +$2.7M 0.25% 96
2019
Q4
$31K Buy
+210
New +$28.2K 0.01% 865

Other funds holding HCA

Aigen Investment Management's HCA Position: Q2 2024 in Review

Aigen Investment Management sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 3,515 shares — an estimated $1.17M sold.

Aigen Investment Management first reported a position in HCA in Q4 2019 and held it in 11 quarters. The position peaked at $4.67M in Q2 2020. 1,155 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Aigen Investment Management reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Aigen Investment Management sold 3,515 HCA Healthcare shares in Q2 2024, an estimated $1.17M.
  • Aigen Investment Management first reported a position in HCA Healthcare in Q4 2019 and held it in 11 quarters.
  • Aigen Investment Management's HCA Healthcare position peaked at $4.67M in Q2 2020.
  • 1,155 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.